0000000000749327

AUTHOR

V. Lebrun-ly

showing 1 related works from this author

444P PRODIGE 25 (FFCD 11-01)-FOLFA: A randomized phase II trial evaluating aflibercept associated with LV5FU2 regimen as first-line treatment of non-…

2020

First line treatmentOncologymedicine.medical_specialtyRegimenOncologybusiness.industryInternal medicinemedicineHematologybusinessAfliberceptmedicine.drugAnnals of Oncology
researchProduct